Hand scales with money and drugs
Pharma

CMS picks 2nd batch of drugs for IRA price talks

Novo’s booming semaglutide franchise for diabetes and obesity is the standout inclusion in this year's list.
Angus Liu Jan 17, 2025 9:28am
AZ

AZ, Daiichi kick off busy 2025 with FDA nod for their 2nd ADC

Jan 17, 2025 9:14pm
Catherine Owen Adams

JPM25: Acadia’s new CEO sets sights on company's first $1B year

Jan 17, 2025 1:22pm
Entresto

Novartis wins 11th-hour bid to block Entresto generic from MSN

Jan 17, 2025 11:41am
green light go go ahead advance yes streetlight

AZ's Calquence, Amgen's Lumakras win new FDA green lights

Jan 17, 2025 11:11am
Asia

Simcere, Takeda and Samsung Biologics—Fierce Pharma Asia

Jan 17, 2025 10:58am
Marketing News

Arvinas commercial chief Northcott steps down

Jan 17, 2025 10:46am

Analysts tip Lilly to drive eightfold Alzheimer's market boom

Jan 17, 2025 9:00am

Gilead's Kite taps Amgen alum as new global commercial head

Jan 16, 2025 10:14am

Aileron straps in for 2025 with a new name: Rein Therapeutics

Jan 16, 2025 9:05am